GlassScriptPhysician profile
Erika Anders
NPI 1871244624
$2,253.97
in general payments reported to CMS, 2019-2025
26 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $399 · 2023: $558 · 2024: $818 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $396.68 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $369.90 | 2022-2024 | Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $217.74 | 2022-2024 | Xiaflex |
| Axonics, INC. | $170.36 | 2022-2024 | Axonics |
| Sumitomo Pharma America, INC. | $144.80 | 2023-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $122.60 | 2022-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Abbvie INC. | $84.96 | 2022-2024 | |
| Tolmar, INC. | $78.18 | 2024-2025 | Eligard, Jatenzo |
| Janssen Biotech, INC. | $77.44 | 2025 | Erleada |
| Teleflex LLC | $64.26 | 2023-2024 | Urolift |
| 180 Medical, INC. | $64.08 | 2024-2025 | Gentlecath Glide, Cure Catheter, Gentlecath |
| Olympus America INC. | $48.42 | 2024 | Itind System |
| Medtronic, INC. | $45.27 | 2022-2023 | Interstim |
| Astellas Pharma US INC | $45.09 | 2025 | Xtandi |
| Progenics Pharmaceuticals, INC. | $39.08 | 2023-2024 | Pylarify |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $38.20 | 2024 | Endosheath Technology |
| Bayer Healthcare Pharmaceuticals INC. | $37.63 | 2023 | |
| Boston Scientific Corporation | $34.37 | 2023-2025 | Axonics, Spaceoar Vue System - 10ml |
| Henry Schein, INC. | $31.53 | 2024 | |
| Sun Pharmaceutical Industries INC. | $30.41 | 2023 | Yonsa |
| Dendreon Pharmaceuticals LLC | $27.37 | 2024 | Provenge |
| Endo USA, INC. | $22.79 | 2025 | Aveed, Xiaflex |
| Coloplast Corp | $19.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.57 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.61 | 2022 | |
| Urovant Sciences INC | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.